Receive our newsletter – data, insights and analysis delivered to you
  1. News
May 18, 2017updated 22 Nov 2018 11:23am

M&As this week: Aoxin Q&M Dental Group, Zevacor Pharma, Amsino Medical Group

Dental equipment developer Aoxin Q&M Dental Group has agreed to acquire 100% of the issued and paid-up share capital of Shenyang Qingaomei Oral Restorative Technology (SYQM) for a purchase consideration of $2.45m.

Dental equipment developer Aoxin Q&M Dental Group has agreed to acquire 100% of the issued and paid-up share capital of Shenyang Qingaomei Oral Restorative Technology (SYQM) for a purchase consideration of $2.45m.

Aoxin has concurrently signed a memorandum of understanding (MoU) to acquire Zhuanghe City Chengguan Street Jiadawei Dental Clinic (ZHJDW) for $1.22m.

The acquisitions will enable Aoxin to expand into dental-related industries in Northern China.

"The acquisitions will enable Aoxin to expand into dental-related industries in Northern China."

Illinois Health and Science (IHS) has signed a definitive agreement to sell Zevacor Pharma, a developer of PET radiopharmaceutical products, to molecular imaging company, Sofie Biosciences.

The acquirer will take over Zevacor Pharma’s manufacturing and distribution network.

In a $13.3m deal, Jiangsu Yuyue Medical Equipment and Supply Company intends to acquire 19.33% stake in Amsino Medical Group Company.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU